FOXP3-TSDR demethylation in tumor-infiltrating CD4+ T cells of colorectal cancer patients was mediated by the increase of TET-2 that catalyzed 5-methylcytosine (5mC) conversion to 5-hydroxymethylcytosine (5hmC) (94). Here, FOXP3 is linked to neoplasm.